The views and opinions expressed in the webinars are those of the speakers. The speakers' views and opinions are not endorsed by the National Psoriasis Foundation or its sponsors.
TreatmentNovember 05, 2019
A Biosimilars Update
If you're wondering about the status of biosimilars since the first biosimilar Inflectra was approved by the FDA in 2016, then this webinar is for you! Hear Dr. Paul Yamauchi, dermatologist at Dermatology Institute and Skin Care Center, Clinical Science Institute in Santa Monica, Ca. and key opinion leader in the field of psoriasis, present the differences between a biologic and a biosimilar, current and upcoming biosimilars, and implications as a treatment option.